Strategic Expansion Sees Acquisition Of Thin Metal Parts (TMP) Inc Which Joins Rebranded Micrometal Group 
Ryoko Pro Reviews: An In Depth Evaluation Of Ryoko Pro WiFi After Testing 
PaySaxas Secures EMI License and Appoints Dmitrii Barbasura as CEO, Ushering in a New Era of Growth 
Novotech Leverages an Intelligent “Cloud, Network & Security” Solution to Propel Global Drug R&D PCI Biotech: Invitation to fourth quarter 2020 results presentation
Oslo, Norway, 18 February 2021 – PCI Biotech’s (OSE: PCIB) fourth quarter and preliminary full…
Y-mAbs Announces Pricing of Public Offering of Common Stock
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Immunicum AB (publ) Announces Year-End Results 2020
Press Release 18 February 2021 Immunicum AB (publ) Announces Year-End Results 2020 OCTOBER-DECEMBER IN SUMMARY…
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
New York, NY and Mainz, Germany, February 17, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE:…
Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results
Conference Call and Webcast to be held March 3, 2021 at 8:00 a.m. Eastern Time…
NexImmune Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GAITHERSBURG, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology…
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Feb. 17, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare…
Better Choice Company Retains Emerging Markets Consulting, LLC (EMC) and Winning Media to Provide Investor/Public Relations Services
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice”),…
Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
LIBERTY 1 and LIBERTY 2 achieved 73.4% and 71.2% response rates in menstrual blood loss,…
Golden Leaf Announces Non-Brokered Private Placement of up to C$11,000,000
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR…
Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock
CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the…
Chinook Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
VANCOUVER, British Columbia and SEATTLE, Feb. 17, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ:…
Codiak Announces Closing of $66.4 Million Public Offering, Including Full Exercise of Underwriters’ Option
CAMBRIDGE, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a…
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
BURLINGAME, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical…
Talis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
MENLO PARK, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
Shockwave Medical Reports Fourth Quarter and Full Year 2020 Financial Results
SANTA CLARA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
Nkarta Announces February and March 2021 Investor Conference Schedule
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a…
vTv Therapeutics Announces Initiation of Multiple Ascending Dose Study of HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
Phase 1 multiple ascending dose study to evaluate safety of HPP737 in healthy volunteers and…
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced…
Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock
AUSTIN, Texas, Feb. 17, 2021 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or…